Detection and identification of tumor-associated protein variants in human hepatocellular carcinomas

scientific article

Detection and identification of tumor-associated protein variants in human hepatocellular carcinomas is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1002/HEP.20060
P698PubMed publication ID14768008
P5875ResearchGate publication ID8881838

P2093author name stringDoris Mayer
Stephanie Lamer
Evelyn Zeindl-Eberhart
Hartmut Manfred Rabes
Peter Roman Jungblut
Sibylle Liebmann
Gundula Jäger
Stephen Chung
Sibylle Haraida
P2860cites workIdentification and characterization of a novel human aldose reductase-like geneQ24310650
Major differences exist in the function and tissue-specific expression of human aflatoxin B1 aldehyde reductase and the principal human aldo-keto reductase AKR1 family membersQ24531853
An ethoxyquin-inducible aldehyde reductase from rat liver that metabolizes aflatoxin B1 defines a subfamily of aldo-keto reductasesQ28572507
A superfamily of NADPH-dependent reductases in eukaryotes and prokaryotes.Q30365249
Proteome analysis of rat hepatomas: carcinogen-dependent tumor-associated protein variantsQ30724085
An integrated proteome database for two-dimensional electrophoresis data analysis and laboratory information management systemQ30736258
Proteomic alterations of the variants of human aldehyde dehydrogenase isozymes correlate with hepatocellular carcinomaQ30790833
Proteome analysis of hepatocellular carcinomaQ30819488
Matrix-assisted laser desorption-ionization mass spectrometry peptide mass fingerprinting for proteome analysis: identification efficiency after on-blot or in-gel digestion with and without desalting proceduresQ30984535
Proteomic analysis and molecular characterization of tissue ferritin light chain in hepatocellular carcinomaQ32116795
New member of aldose reductase family proteins overexpressed in human hepatocellular carcinomaQ34463575
Sequence and expression levels in human tissues of a new member of the aldo-keto reductase familyQ34474576
Proteome database of hepatocellular carcinoma.Q34642472
The prognostic molecular markers in hepatocellular carcinomaQ34668320
Disease proteomicsQ35084579
Glutathione transferases and cancerQ35815703
Enzyme relationships in a sorbitol pathway that bypasses glycolysis and pentose phosphates in glucose metabolismQ37603572
Xenobiotic carbonyl reduction and physiological steroid oxidoreduction. The pluripotency of several hydroxysteroid dehydrogenasesQ40602502
Identification of differentially expressed proteins between human hepatoma and normal liver cell lines by two-dimensional electrophoresis and liquid chromatography-ion trap mass spectrometryQ40853089
Further characterization of a rat hepatoma-derived aldose-reductase-like protein--organ distribution and modulation in vitroQ41096240
Expression of tumor-associated protein variants in chemically induced rat hepatomas and transformed rat liver cell lines determined by two-dimensional electrophoresisQ41484361
Two-dimensional polyacrylamide gel electrophoresis in experimental hepatocarcinogenesis studiesQ41484368
Variant protein patterns in hepatomas and transformed liver cell lines as determined by high resolution two-dimensional gel electrophoresis (2DE)Q41614723
Overexpression of aldose reductase in liver cancers may contribute to drug resistanceQ43549654
The role of aldose reductase in sugar cataract formation: aldose reductase plays a key role in lens epithelial cell death (apoptosis).Q43577683
Analytical techniques for cell fractions. XXI. Two-dimensional analysis of serum and tissue proteins: multiple isoelectric focusingQ43582812
Analytical techniques for cell fractions. XXII. Two-dimensional analysis of serum and tissue proteins: multiple gradient-slab gel electrophoresisQ43974879
Inhibition of aldose reductase enhances HeLa cell sensitivity to chemotherapeutic drugs and involves activation of extracellular signal-regulated kinasesQ44190175
The aldo-keto reductases and their role in cancerQ47959317
A new nomenclature for the aldo-keto reductase superfamilyQ48772502
A new method to assign immunodetected spots in the complex two-dimensional electrophoresis pattern.Q50528987
Two-dimensional electrophoresis of proteins: an updated protocol and implications for a functional analysis of the genome.Q53011878
Analysis by high-resolution two-dimensional electrophoresis of differentiation-dependent alterations in cytosolic protein pattern of HL-60 leukemic cells.Q53033706
Micropreparative immobilized pH gradient two-dimensional electrophoresis in combination with protein microsequencing for the analysis of human liver proteins.Q53460679
PUBLIC HEALTH:Reducing Liver Cancer--Global Control of AflatoxinQ58296818
Elevation of aldose reductase gene expression in rat primary hepatoma and hepatoma cell lines: implication in detoxification of cytotoxic aldehydesQ71740598
Isolation of differentially expressed aldose reductase in ovaries after estrogen withdrawal from hypophysectomized diethylstilbestrol treated rats: increased expression during apoptosisQ73064967
Two-dimensional electrophoresis of liver proteins: characterization of a drug-induced hepatomegaly in ratsQ73990197
A distinct repertoire of autoantibodies in hepatocellular carcinoma identified by proteomic analysisQ74405612
P433issue2
P407language of work or nameEnglishQ1860
P304page(s)540-549
P577publication date2004-02-01
P1433published inHepatologyQ15724398
P1476titleDetection and identification of tumor-associated protein variants in human hepatocellular carcinomas
P478volume39

Reverse relations

cites work (P2860)
Q35991845A comparative proteomic study identified LRPPRC and MCM7 as putative actors in imatinib mesylate cross-resistance in Lucena cell line.
Q54364816AKR1B10 is associated with smoking and smoking-related non-small-cell lung cancer.
Q52607803Aldo-Keto Reductases Mediated Cytotoxicity of 2-Deoxyglucose: A Novel Anticancer Mechanism.
Q42366521Aldose reductase interacts with AKT1 to augment hepatic AKT/mTOR signaling and promote hepatocarcinogenesis
Q46003997Aldose reductase regulates hepatic peroxisome proliferator-activated receptor alpha phosphorylation and activity to impact lipid homeostasis.
Q35893754Biological role of aldo-keto reductases in retinoic Acid biosynthesis and signaling
Q41128802Can proteomics lead to the discovery of real biomarkers for HCC?
Q36851342Characterization of the cancer chemopreventive NRF2-dependent gene battery in human keratinocytes: demonstration that the KEAP1-NRF2 pathway, and not the BACH1-NRF2 pathway, controls cytoprotection against electrophiles as well as redox-cycling comp
Q24294264Comparative functional analysis of human medium-chain dehydrogenases, short-chain dehydrogenases/reductases and aldo-keto reductases with retinoids
Q33764377Contribution of laser microdissection-based technology to proteomic analysis in hepatocellular carcinoma developing on cirrhosis
Q36227969Current progress in proteomic study of hepatitis C virus-related human hepatocellular carcinoma
Q42199276Diallyl sulfide protects against N-nitrosodiethylamine-induced liver tumorigenesis: role of aldose reductase
Q37538963Epithelial-mesenchymal transition induces endoplasmic-reticulum-stress response in human colorectal tumor cells
Q51069851Evaluation of compound selectivity of aldo-keto reductases using differential scanning fluorimetry.
Q37353089Evidence-based diagnosis and locoregional therapy for hepatocellular carcinoma
Q33580721Expression of aldo-keto reductase family 1 member b10 in the early stages of human hepatocarcinogenesis
Q33250475Global proteomic analysis of microdissected cirrhotic nodules reveals significant biomarkers associated with clonal expansion.
Q38366329Glycosylation and liver cancer
Q33211462Identification of a new marker of hepatocellular carcinoma by serum protein profiling of patients with chronic liver diseases
Q27689445Identification of a novel polyfluorinated compound as a lead to inhibit the human enzymes aldose reductase and AKR1B10: structure determination of both ternary complexes and implications for drug design
Q33925676Identification of two portal vein tumor thrombosis associated proteins in hepatocellular carcinoma: protein disulfide-isomerase A6 and apolipoprotein A-I.
Q37040963Identification of up-regulated genes in malignant glioma with subtraction hybridization: preliminary screening studies
Q35550716Inhibition of aldose reductase activates hepatic peroxisome proliferator-activated receptor-α and ameliorates hepatosteatosis in diabetic db/db mice.
Q91726315MicroRNAs in Animal Models of HCC
Q36743649Mutations in the C-terminus of the X protein of hepatitis B virus regulate Wnt-5a expression in hepatoma Huh7 cells: cDNA microarray and proteomic analyses
Q34578790Non-alcoholic fatty liver disease proteomics
Q33298434Oncoproteomics of hepatocellular carcinoma: from cancer markers' discovery to functional pathways.
Q37105040Oxidation of PAH trans-dihydrodiols by human aldo-keto reductase AKR1B10.
Q35070288Predicting early intrahepatic recurrence of hepatocellular carcinoma after microwave ablation using SELDI-TOF proteomic signature
Q39079387Promising anti-tumor properties of bisdemethoxycurcumin: A naturally occurring curcumin analogue
Q38584282Proteome Analyses of Hepatocellular Carcinoma
Q40075098Proteomic and transcriptomic studies of HBV-associated liver fibrosis of an AAV-HBV-infected mouse model
Q36519019Proteomics for the early detection and treatment of hepatocellular carcinoma
Q89510543Retinoic Acids in the Treatment of Most Lethal Solid Cancers
Q28477432ShRNA-targeted centromere protein A inhibits hepatocellular carcinoma growth
Q27702584Structural Determinants of the Selectivity of 3-Benzyluracil-1-acetic Acids toward Human Enzymes Aldose Reductase and AKR1B10
Q27649354Structural basis for the high all-trans-retinaldehyde reductase activity of the tumor marker AKR1B10
Q41140599Surveillance and diagnosis of hepatocellular carcinoma in patients with cirrhosis